机译:临床前研究中鼻内流感疫苗筛选方法的研制
Department of Safety Research on Blood and Biological Products National Institute of Infectious;
Department of Safety Research on Blood and Biological Products National Institute of Infectious;
Department of Safety Research on Blood and Biological Products National Institute of Infectious;
Influenza Virus Research Center National Institute of Infectious Diseases;
Department of Safety Research on Blood and Biological Products National Institute of Infectious;
Department of Safety Research on Blood and Biological Products National Institute of Infectious;
Laboratory of Vaccine Science WPI Immunology Frontier Research Center Osaka University;
Toxicogenomics Informatics Project National Institutes of Biomedical Innovation Health and;
Laboratory of Vaccine Science WPI Immunology Frontier Research Center Osaka University;
Laboratory of Animal Reproduction and Development Graduate School of Agricultural Science Tohoku;
Department of Safety Research on Blood and Biological Products National Institute of Infectious;
Department of Safety Research on Blood and Biological Products National Institute of Infectious;
Biomarkers; Vaccine safety; Preclinical study; Adjuvant; Alum; NanoSiO2; Pam3CSK4; DMXAA; QuantiGene plex;
机译:临床前研究中鼻内流感疫苗筛选方法的研制
机译:随机的双盲,受控临床试验,以评估用佐剂Lth(αK)的鼻内给药的三价灭活流感疫苗的安全性和免疫原性:我研究的一部分
机译:鼻内施用的灭活的三价病毒体配制的流感疫苗的安全性和免疫原性,其中含有大肠杆菌热不稳定毒素作为粘膜佐剂。
机译:新型鼻内流感疫苗的安全性和免疫原性的临床前和临床调查
机译:用作鼻内免疫疫苗佐剂的明胶纳米颗粒。
机译:H5N1流感病毒鼻内疫苗粘膜佐剂的研制
机译:改进季节性流感疫苗的佐剂:MVA-NP + M1与灭活流感疫苗共同给药的临床前研究。